Combination approaches integrating metabolic inhibitors with chemotherapy, radiotherapy, or immunotherapy are emerging as promising strategies to overcome resistance and improve clinical outcomes
No clinical trial has answered this question definitively yet, but the mechanistic rationale is compelling
An enzyme called tyrosinase is needed to create melanin (the pigment that causes the brown spots) and while several other skin lightening agents work to inhibit the synthesis of tyrosinase itself (like vitamin C or licorice), arbutin lets tyrosinase be and rather hinders the melanin-forming activity of the enzyme
TB-500 contributes a distinct mechanism focused on structural protein dynamics and cellular movement during wound recovery
8 L cells in the gastrointestinal tract sense the presence of nutrients in the gut lumen during feeding and secrete GLP-1 to act on multiple tissues, including the pancreas, intestines, and brain
Precision Testing Evaluates antioxidant and detox pathway genetics that shape resilience and aging